No Data
No Data
Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 28% Undervaluation?
Proto Labs' (NYSE:PRLB) Conservative Accounting Might Explain Soft Earnings
Benchmark Co. Maintains Proto Labs(PRLB.US) With Buy Rating, Maintains Target Price $45
Proto Labs Is Maintained at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Maintains Proto Labs(PRLB.US) With Buy Rating, Raises Target Price to $50
Cantor Fitzgerald Keeps Their Buy Rating on Proto Labs (PRLB)